Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection
Clinical trial NCT04640233 · UNKNOWN
Trial details
- NCT number
- NCT04640233
- Sponsor
- Dr. Reddy's Laboratories Limited
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-08-01
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.